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Objective. Increasing the quality of life (QoL) of patients with chronic fatigue is challenging 
because recovery is seldom achieved. Therefore, it is important to identify processes that 
improve QoL. This study examined the extent of improvement related to cognitive behaviour 
group therapy (CBT), and whether improvement is affected by initial levels of acceptance and 
neuroticism.  
Methods. Eighty CFS patients followed CBT, and self-reported (pre-post design) on mental 
and physical QoL (MQoL and PQoL), fatigue, acceptance, neuroticism. The extent of 
improvement was analyzed using t-tests, effect sizes, and clinically significant change criteria. 
Whether acceptance and neuroticism at baseline predicted changes, was analyzed by means of 
correlation and regression analyses.  
Results. Significant improvement was found for all variables. The effect size for MQoL and 
PQoL was small; for acceptance and fatigue moderate. About 20% (MQoL) to 40% (fatigue) 
of the participants clinically improved. 
Pre-treatment level of acceptance was negatively correlated with changes in MQoL, not with 
PQoL changes. Neuroticism pre-treatment was positively related with MQoL changes. 
Regression analysis showed an effect of acceptance on changes in MQoL beyond the effect of 
neuroticism.  
Conclusions: Although CBT is an evidence-based treatment, the sizes of the effects are often 
small regarding QoL. Our study also revealed small effect sizes.  Our study showed that 
patient characteristics at baseline were significantly associated with MQoL outcome; 
indicating that CFS patients with high neuroticism or with a low acceptance show more 
improvement in MQoL. We propose to specifically target acceptance and neuroticism before 














Chronic fatigue syndrome (CFS) is a complex syndrome with severe disabling fatigue 
lasting for at least 6 months as the major criterion according to Centre for Disease Control [1]. 
The precise medical pathophysiology remains unknown, and many researchers adopt a bio-
psycho-social account for this ‘medically unexplained syndrome’, acknowledging the 
importance of complex and dynamic interactions between biological, psychological and social 
factors. Within this account, cognitive behavioural models have become increasingly popular 
[2-5]. These models propose a set of predisposing factors (e.g., genetics, personality 
characteristics, and life events), precipitating factors (e.g., physiological factors and general 
distress) and perpetuating factors (e.g., physiological, cognitive, behavioural, and social 
reactions) that each may contribute to the development and maintenance of CFS [3-8].  
Cognitive behavioural models are equally well used to deliver treatments for CFS. 
Most often cognitive-behavioural therapy (CBT) for CFS targets cognitive and behavioural 
perpetuating factors such as the misbalance between rest and activity, and the belief that they 
have to be perfect in every situation, potentially resulting in ignoring their physical limits.  
Research has shown that CBT improves physical functioning and fatigue reduction 
immediately and some time after treatment [9,10]. Nevertheless, complete recovery is 
uncommon.  
A recent meta-analytical study of Castell and colleagues shows an overall effect size 
for CBT of 0.33, which is small according to Cohen’s recommendations [10,11]. This 
research group suggested that the variability in fatigue outcomes in CBT reflects the existence 
of moderating variables and examined illness characteristics and treatment characteristics. 
Regarding illness characteristics, illness duration does not affect the outcome of CBT in CFS. 
Regarding treatment characteristics, total duration of CBT (in hours) showed a positive 
influence on the outcome. No evidence was found that the treatment format (group or 
individual) and treatment duration (weeks) affected the effect size of CBT [10]. Although 
group programs are often preferred because of the cost efficacy and they involve peer support, 
support groups without therapy do not yield similar outcome results as CBT [12].  
 Other studies indicate that patient characteristics also matter: CBT effect increases 
when patients are less focused on their symptoms and are less anxious about it [13-14]. Until 
now the role of illness acceptance in CBT has received little attention  [15].   
Illness acceptance is defined as “recognizing the need to adapt to a chronic illness 
while perceiving the ability to tolerate the unpredictable, uncontrollable nature of the disease, 
and handle its adverse consequences” [16-p1027]. This way of coping with adversity is more 
4 
 
and more acknowledged to be related to a good adjustment to chronic illness [17-22]. Its 
function is also well-articulated in self-regulatory models of coping [23-25].One example of 
such a model is the ‘Dual-Process Model of Coping of Brandtstädter and colleagues’ [26-27], 
which distinguishes between two complementary coping strategies: accommodative coping 
and assimilative coping. ‘Assimilative coping’ is characterized by active attempts to control 
the stressor and solve the problem, in order to continue with the pursuit of one’s life goals. 
When a problem remains insoluble and blocks life goals, stress increases and a transition from 
assimilative to accommodative coping may be required. In accommodative coping “the 
structure of individual cognitions and valuations is modified to make the given situation 
appear less negative or more acceptable” that leads to the disengagement from the blocked 
goals, and goal adjustment or  reengagement with feasible goals [26-p58]. Acceptance of the 
adverse consequences and uncontrollability of an insoluble problem is often considered as a 
key process in accommodative coping [16, 28]. Chronic illness, such as CFS, may be 
considered as a problem that cannot (yet) be cured or solved, and where an accommodative 
coping strategy and illness acceptance is to be preferred. In line with this view, cross-sectional 
studies indicate that acceptance plays a role in adjustment to chronic illnesses, amongst which 
CFS and that acceptance has been found to be associated with a better mental health-related 
quality of life (MQoL) [17, 27, 29-31]. Of further interest are the results of Brooks and 
colleagues, who found that CBT for CFS resulted in an increase of acceptance, and that lack 
of acceptance was associated with fatigue and physical functioning [15].  In our study, we are 
interested whether acceptance before the start of CBT predicts the effects of treatment 
regarding health-related quality of life and fatigue.  
Another patient characteristic which we will examine in  relation to CBT treatment is 
the personality. Personality traits are related to how individuals cope with problems [32]. In 
particular the trait ‘neuroticism’, which is characterized as the degree of emotional instability, 
associated with a tendency to experience negative emotions, a vulnerability for stress and for 
psychopathology,  may be relevant [33]. First, neuroticism is presumed to be one of the 
predisposing factors of CFS in [4-5,34] in biopsychosocial accounts. Second, there is 
preliminary evidence that neuroticism  negatively influences illness acceptance and mental 
wellbeing in CFS [31]. In our study, therefore, we wanted to examine whether neuroticism 
before treatment negatively influences the effects of CBT.  
Next to fatigue, quality of life (QoL) should be a substantial outcome parameter to 
evaluate the condition of patients after treatment. QoL often has two dimensions: a mental 
health quality of life (MQoL) and a physical health quality of life (PQoL). Increasing QoL in  
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patients with CFS is a challenge because recovery is difficult to achieve. Research shows that 
the QoL is lower in CFS patients compared with other chronic ill and healthy control groups 
[35-37]. One of the possible reasons is that overall patients with CFS score higher on 
neuroticism, which is related to a more negative perception of symptoms, disability, and 
health [38-39]. Another reason might be that patients with CFS have difficulties with 
accepting the fatigue and its devastating consequences, especially  because CFS is regarded as 
a medically unexplained illness [8]. Although it has already been shown that non-accepting 
cognitions seem to lead to maladaptive activity patterns in patients with CFS which results in 
increased fatigue, frustration and a negative QoL [30-31, 40-41], more research is needed to 
highlight the importance of acceptance for adjusting to a life with CFS.  
In sum, this study examined the extent of improvement related to cognitive behaviour 
group therapy (CBT) on MQoL and PQoL, fatigue and acceptance, using a pre-post design 
without no-treatment control group, and, of most importance to this study, whether the 
observed improvement in outcomes is affected by initial levels of acceptance and neuroticism. 
We will use three methods (statistical, practical, and clinical) to evaluate the pre-post 
treatment changes in mental, and physical health-related QoL, fatigue and acceptance. 





Patients with CFS from the general internal medicine outpatient clinic of the Ghent 
University Hospital were invited to participate in the study in the period 2009-2011. They 
experienced group CBT over a period of 6 months. The pre-treatment data were collected 
during a psychological assessment phase, which was a part of a multidisciplinary diagnostic 
procedure. In this procedure psychological assessment was the second examination after the 
diagnostic investigation by the internist. The psychological assessment was followed by a 
psychiatric assessment and a multidisciplinary patient discussion, in which the diagnosis of 
CFS according to the Fukuda et. al. criteria [1] is made and treatment modalities are 
discussed. Between the baseline measurement and the start of CBT-treatment there was a 
period of approximately 4-6 months. The post-treatment data were collected at the end of the 
treatment. The duration of the treatment was 6 months. There was a mean of 12.4 months 
between pre and post-treatment measurement. The number of group members ranged from 8-
12. All patients provided informed consent, and the study was approved by the local ethics 
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committee. Inclusion criteria of the study were:  knowledge of Dutch language (in order to 
fill-in the Dutch questionnaires), age (minimum 18 years old), and a diagnosis of CFS 
according to the CDC criteria [1] with a strict exclusion for medical (internal and psychiatric) 
diagnoses that could explain the fatigue symptoms. The data from the pre-treatment 
questionnaires of the patients who did not complete the treatment program were excluded, 
which resulted in 80 patients (73 women and 7 men). Various reasons were given for drop-
out: impossible combination work-therapy, other medical diagnoses received during 
treatment, and family circumstances. 
The group CBT was conducted by four psychologists trained by a cognitive 
behavioural therapist for this program.  We chose a group CBT programme because of cost 
efficacy and the putative value of the peer support. CBT aimed at increasing functioning, and 
its objective and content  are comparable with manuals of other CBT trials [9,12]. The 
treatment program consisted of twelve, 2-hour sessions, and a session was held every 2 
weeks. The program included stress management (psycho-education on stress and fatigue and 
a relaxation therapy according to the Jacobson technique); gradual activity management (in 
the first phase patients are learning to find a balance between rest and activity by activity 
planning, in a second phase, activity was gradually built up); sleep management (psycho-
education on sleep hygiene and sleep disorders, and stimulating a regular sleep pattern); and 
cognitive therapy (identifying and challenging negative cognitions about fatigue; and 




In this study we used self-report questionnaires to assess the following variables: 
mental and physical QoL, fatigue severity, acceptance, and neuroticism. All participants 
completed the questionnaires described below. 
 
The 36-item Short Form Health Survey (SF-36) 
The SF-36 is a 36-item questionnaire that consists of 8 subscales: 4 mental health 
subscales (vitality, social functioning, role-emotional, and mental health) and four physical 
health subscales (physical functioning, role-physical, bodily pain, and general health). There 
are two summary scores, the ‘mental and physical component summary scores’, which are 
used for our analyses. MQoL and PQoL refer to these summary scores. The items are scored 
on a 2- to 6-point Likert scale with the total scores transformed to scale values from 0 to 100. 
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The higher the summary scores, the better the quality of life. The SF-36 is a reliable and valid 
instrument with a Cronbach’s alpha coefficient of 0.90 [42-43].  
 
Checklist interpersonal attachment strength (CIS) 
We used the ‘fatigue severity’ subscale of the CIS as an indicator of fatigue.  The CIS 
is a 20-item questionnaire with 4 subscales: ‘Fatigue severity’ (8 items; e.g., ‘I feel tired‘); 
‘Concentration’ (5 items); ‘Motivation’ (4 items); and ‘Physical activity level’ (3 items). The 
items are scored on a 7-point scale (from ‘0=correct’ to ‘6=incorrect’). The total scores are 
transformed to scores from 0-7. The CIS has been shown to have good reliability and validity, 
and the subscale ‘fatigue severity’, which we used in our study, has a Cronbach’s alpha 
coefficient of 0.88 [44].  
 
Illness Cognition Questionnaire (ICQ)  
Acceptance was assessed by the subscale ‘acceptance’ of the ICQ. The questionnaire 
has three subscales, each with 6 items: ‘Acceptance’ (e.g., ‘I have learned to accept the 
disability of my disease’), ‘Helplessness’, and ‘Disease benefits’. Items are scored on a 4-
point scale with a range from 1 to 4 (from 1= disagree to 4= totally agree). The maximum 
score is 24. The ICQ is a reliable and valid instrument, with a Cronbach’s alpha of 0.90 for 
the acceptance subscale [16, 28].  
 
NEO-Five Factor Inventory (NEO-FFI) 
 This 60-item Dutch version of the revised NEO Five Factor Inventory measures 5 
personality traits: neuroticism, extraversion, openness, agreeableness, and conscientiousness, 
based on the Big Five Personality model. Each trait consists of 12 items, and each item is 
scored on a 4-point scale (from ‘0=totally disagree’ to ‘4=totally agree’). Only the trait 
‘neuroticism’ was used in our analyses. Research has shown that the NEO-FFI is sufficiently 
reliable (alpha coefficients vary between 0.68 and 0.86). Also the construct and concurrent 
validity has been well documented [45-46]. Neuroticism was measured only at pre-treatment 




Data were analysed with SPSS version 19.0.  
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First, we investigated the pre-post treatment changes (Xchange = Xpost – Xpre)  in MQoL, PQoL, 
fatigue and acceptance using statistical, practical, and clinical criteria [47-52]. Next, we 
investigated whether the changes after cognitive behaviour group therapy (CBT) in 
MQoL/PQoL and fatigue were affected by initial levels (before treatment) of acceptance and 
neuroticism scores. For all analyses, there were no problems with regard to normality or 
collinearity. 
  
Analyses of pre-post CBT changes 
We used paired sample t-test to test whether post-CBT scores were statistically 
significant from pre-CBT scores for MQoL, PQoL, fatigue and acceptance [50].                           
We used independent Cohen’s d as effect size to identify the practical significance of 
the observed pre-post CBT changes. Cohen’s d = (M1 – M2) / SD pooled. Cohen’s d is a 
standardized difference score, and provides an index that allows easy comparison between 
different outcomes [48-50]. For comparison with the norms of Cohen (1988), we calculated 
effect sizes for independent samples using the formula of Dunlap and colleagues (see 
Borenstein et al., 2009) [53-54]. Means, standard deviation from both the pre- and post-
measurement were used, as well as the correlation between the pre- and post measure [53].  
Finally we explored the clinical significance of the pre-post CBT change, and 
calculated how many patients improved. Two factors were taken into account.: (1) how 
statistically reliable the change is by calculating a reliable change index, and (2) how the 
individual post-treatment score of our dysfunctional patient sample relates to a representative 
functional group by calculating a cut-off point [48,49]. Although there is no consensus about 
which method should be reported based on clinically significant change, we based our 
statistical analysis on the frequently used formulas of Jacobson [51,52]:   
(1) We calculated a reliable change index (RCI) for each patient, based on the 
formula: RCI = (Xpost – Xpre)/Sdiff.  Sdiff is calculated with the formula √2(SE)², 
where SE=standard error of measure=SD√1-rtest-retest reliability. When the RCI >1.96 
(p<.05), we may consider the post-treatment score is representing real, reliable 
change. For fatigue severity, there was a reliable change when RCI<-1.96, because 
here lower scores mean more function whereas higher scores indicate less function 
(or more dysfunctionality). 
(2) We calculated cut-off points for the variables of interest: acceptance, 
PQoL/MQoL, and fatigue. As we had no healthy reference groups with which to 
compare acceptance (ICQ), PQoL (SF-36), MQoL (SF-36), and fatigue (CIS), we 
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used the formula: a = Mpre + (2SDpre). We inverted the direction (-2SDpre) for 
fatigue. This resulted in the following cut-off points: 18.43 (ICQ acceptance), 
87.52 (MQoL), 52.83 (PQoL), and 5.33 (fatigue).  
When the clinical change is statistically reliable (i.e., not occurring by measurement error) 
and the cut-off point at the post-treatment measurement is crossed, patients might be 
considered as ‘recovered’ on that variable. When clinical change is statistically reliable but 
the post-treatment score does not cross the cut-off point, patients are considered ‘improved’. 
Finally, when the clinical change is statistically reliable in the negative direction, patients are 
considered ‘deteriorated’. 
 
Correlation and regression analyses  
 We correlated (Pearson correlations) the change in score with baseline measures 
(fatiguepre, acceptancepre and neuroticismpre), and the change in the variables (MQoLchange, 
PQoLchange, fatiguechange and acceptancechange). 
In a regression analysis, we explored the unique role of acceptance at baseline in 
predicting change beyond the effect of neuroticism. For that purpose, only those variables 
with a significant correlation were used. We used ‘enter’ as the inclusion method with 
MQoLchange as the dependent variable, and baseline neuroticism (step 1) and acceptance (step 





The mean age in our sample (73 women and 7 men) was 43.15 years (SD= 8.54, 
range=24-57 years). We compared the data regarding the study variables of this sample with 
an independent sample of 117 non-treated CFS patients (collected during the diagnostic 
screening on CFS) [25]. Mean fatigue severitypre was 6.43 (SD=0.55) comparable to the mean 
fatigue in the independent sample (M=6.37, SD=.76). The mean of acceptancepre (M=11.73, 
SD=3.35) was also comparable (previous sample: M=11.97, SD=3.49). The neuroticismpre 
mean score was 36.29 (SD=8.79) in this sample, 36.90 (SD=8.63) in our previous sample. 
The summary scores of the SF-36 were also similar: MQoL (previous sample): 49.41 
(SD=17.89), our sample: 50.98 (SD=18.27), PQoL (previous sample: 31.58 (SD=12.52), our 




Pre-post CBT results  
Relating to statistical significance,  patients reported more acceptance during the post-
treatment phase (M=13.91, SD= 3.71) than during the pre-treatment phase (M=11.73, 
SD=3.35, t(79)= 5.72, p<.001). Also fatigue severity showed a significant improvement 
(t(79)= -4.59, p<.0001) from pre to post-treatment. MQoL (t(79)= 3.47, p<.001) and PQoL 
(t(79)= 3.42, p<.001) also showed a significant improvement (Table 1). 
Relating to the practical significance, the effect size (Cohen’s d) was moderate for 
acceptance (0.61) and fatigue severity (-0.56) but small for MQoL (0.37) and PQoL (0.34) 
(Table 1).       
Relating to clinically significant change, our sample (n=80)  showed 16 patients who 
had a reliable change (‘improved’) in MQoL, but none crossed the cut-off point of 87.52 and 
could, therefore, be considered recovered. Four patients showed a deterioration in MQoL.  
PQoL was improved for 21 patients, with 6 recovered. Seven patients showed deterioration in 
PQoL. We found that fatigue severity improved for 32 patients, recovery was found in 13 
patients, 8 patients became worse. For acceptance, 19 patients reported improvement with 4 
crossing the cut-off point. Two patients had a reliable change in the negative direction 
(‘deterioration’), and had worse acceptance after treatment (Table 2). 
 
Correlation and regression analyses 
Acceptancepre was negatively correlated with MQoLchange (r= -0.32, p<.01) and 
acceptancechange (r= -0.40, p<.01), but not with PQoLchange (r= -0.03) or fatiguechange (r= 0.10). 
Neuroticismpre showed a significant positive relationship with MQoLchange (r=.27, p<.05), but 
not with PQoLchange (r= 0.09), fatiguechange (r= -0.16), or acceptancechange (r= 0.03). Fatiguepre 
showed no significant correlations with change variables. Based upon this pattern of 
correlation, we only performed a regression analysis with MQoLchange as outcome.  
 In the regression analysis with MQoLchange as the dependent variable, we found that 
neuroticismpre  had a significant contribution for 7% (β=0.27, Fchange (1,78)=5.88, p< .05, 
R
2
change= 0.07). However, neuroticismpre was no longer significant when acceptancepre was 
entered. Acceptancepre  accounted for 5% additional variance in explaining MQoLchange (β= -
0.26, p<.05, Fchange (1,77)=4.59, p< .05, R
2
change= 0.05). The final model explained 10 % 
of the variance of MQoLchange (adjusted R
2
=0.10, F (2,77)=5.37,  p<.01) and was significant 






The primary goal of this study was to evaluate whether acceptance and neuroticism 
measured during pre-treatment was predictive of improvement in mental and physical QoL 
and fatigue for patients with CFS who followed a CBT treatment. We first focus upon the 
extent of improvement due to cognitive behaviour group therapy (CBT) and, then, focus upon 
whether improvement was affected by initial levels of acceptance and neuroticism.  
Overall, the pattern of results in our study indicates that CBT leads to an improvement 
of mental and physical wellbeing, fatigue and acceptance. For acceptance and fatigue, the 
effect size was moderate, for QoL the effect sizes are small, which is comparable to the effect 
sizes  reported in the meta-analysis of Castell et al. [10]. Although our results corroborate the 
overall consensus that CBT is an evidence-based treatment for CFS, its effects are not the 
same for all patients. CBT seems to produce variable effects both in terms of how many 
patients benefit from treatment, and in terms of the extent of change experienced. There was a 
clinical improvement (statistically reliable changes taken the measurement error into account) 
in all variables of interest for 20% up to 40% of the patients. For example, 40% of the patients 
showed improvement in fatigue, but fatigue became worse after treatment in 10%. Only 
16,3% of the patients could be classified as recovered according to our criteria, which is in 
line with previous research [55]. The findings for acceptance and physical QoL are less 
favourable but similar. For mental QoL, only 20% of patients reliably improved, whereas 
none could be classified as recovered. Analyzing data using criteria of clinical significance 
reveals a far more nuance picture than the often used statistical criteria. CFS is a chronic 
condition, and seems to remain a chronic condition for many, even after CBT.  It is worth 
keeping the following two remarks in mind when interpreting the above criteria. First, 
although one may easily attribute the here observed changes to CBT, one should be careful in 
doing so. Our study did not include a no-treatment control group. It may thus be possible that 
natural variation in outcomes occurs independently of treatment [56]. Second, a focus upon 
clinical significance is much needed in evaluating treatment efficacy and effectiveness, but 
finding a clear-cut criterion for recovery is an hazardous enterprise in chronic conditions. 
More research is needed to define exactly what is meant by recovery, and to provide data 
from which clinical cut-offs can be derived. Moreover, we have to keep in mind that patients 
scoring their QoL after treatment is closely related to their operationalization of the concept of 
‘recovery’, this operationalization can change eventually during psychological treatment 
[4,56]. Despite these considerations our results show the least clinical significant change in 
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mental and physical QoL, which may suggest that we have to focus more on other factors to 
enhance a better QoL. 
Despite the good evidence base for CBT, more research is needed to understand for 
whom CBT is effective and how exactly the change in CBT is accomplished [57].  Therefore, 
an important challenge is not to identify whether CBT works, but for whom CBT works. In 
our study we addressed this issue by exploring whether acceptance and neuroticism at 
baseline were predictive of change after CBT. We observed that these variables were 
predictive of changes in mental QoL. Low levels of acceptance, and high levels of 
neuroticism at baseline were associated with a larger improvement in mental QoL. This is 
remarkable. One may easily believe that those low in acceptance and high on neuroticism 
would benefit less from a group therapy focused upon the improvement of  functioning 
because clinically, the improvement in mental QoL of more neurotic patients is not always 
clear because those patients remain reporting a lower mental QoL before and after treatment 
in comparison with the patients scoring lower on neuroticism [31].  The reverse seems to be 
the case in our study. We suspect that several aspects of the treatment (structure of the 
programme, activity management, psycho-education on CFS and stress, and stress-
management) effectively diminish a dominant focus on symptoms, extinguish avoidance, and 
also stimulate acceptance [12-14]. These findings are encouraging for therapists who work 
with this type of patients. Moreover, the results  suggest that we have to keep in mind that 
patients with low acceptance and a neurotic personality should not be excluded, and can 
benefit from a group CBT programme [58].  
Of further note in this context is that acceptance seems to be more important than 
neuroticism. Acceptance at baseline had a unique role in predicting changes in mental QoL 
beyond the effect of neuroticism. Our results indicate that there is need for more systematic 
focus on acceptance in the psychological assessment before treatment in this population. This 
is well in line with research in chronic pain: improving acceptance is considered as more 
important than other coping strategies to achieve treatment success [59-64]. It may well be 
that a more explicit focus on acceptance will also prove beneficial for patients with chronic 
fatigue syndrome. Low acceptance at baseline can be considered as an extra indication for 
group CBT treatment because of its impact on QoL, provided the therapeutic goal of the CBT 
broadens from only focussing on decreasing the fatigue (curing) to also focussing on ‘a better 
QoL’ (caring). As yet, research on the role of acceptance in CFS is limited. Only a few studies 
has examined acceptance as predictor of health-related quality of life, and one recent study 
emphasized the importance of  acceptance within a treatment of CFS patients [15]. More 
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research is required to provide therapists and researchers more insight into the role of 
acceptance in treatment. 
Of further interest is that although our treatment did not include specific acceptance 
interventions, acceptance was improved. A clinically relevant improvement in acceptance for 
nearly a quarter of the patients (23.8%) suggests that traditional, group cognitive-behavioural 
interventions can influence the process of acceptance. Along this line, a study in chronic pain 
patients also showed statistically significant and clinical changes in acceptance after 
traditional CBT [65]. The fact that acceptance may be improved despite not being an explicit 
treatment target, may explain why Hofmann et al. observed that acceptance-orientated 
treatments (ACT and Mindfulness) do not result in better results than cognitive behaviour 
therapy (CBT) [66]. Interventions targeting acceptance may be consistent with and 
complementary to a CBT approach
 
[66]. A remaining challenge will be to refine CBT in order 
to improve its effects. We present here some ideas: (1) specific educational elements 
concerning acceptance; (2) more focus on cognitive reframing provided it is within a context 
of  accommodative coping; (3) stimulating behavioural experiments in which an acceptance is 
central. However, we acknowledge that in order to realise these objectives, therapists need to 
have the appropriate therapeutic skills and competences. Additional research will be 
important to investigate what is necessary to enhance the impact of acceptance and to refine 
CBT interventions accordingly.  
We conclude that the strength of this study lies in the fact that the results contribute to 
a better estimation of which patient characteristics predict the improvement by CBT. 
Although acceptance and neuroticism at baseline explained only about 10% of the variance of 
change in mental health quality of life, these findings gives support to the idea that these 
characteristics have to be considered with regard to psychological treatment for CFS patients. 
Which cognitive behavioural therapeutic factors are effective and responsible for these 
findings remains to be investigated, but systematically assessing acceptance and personality 
characteristics before and after treatment can initiate research on appropriate 
psychotherapeutic interventions. Furthermore, we have shown that, although neuroticism 
might be high, CBT has an effect on mental QoL. This may have an impact on the screening 
of patients who are eligible for these treatment programmes.  Whether it is more efficient to 
divide the groups (more and less neurotic) has to be considered and addressed in further 
research on this matter. Another consideration might be to provide a more tailored group 
programme, which might mean a longer duration of therapy. In the meta-analysis of Castell et 
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al. the number of treatment hours was indeed shown to be a significant predictor of the effect 
of CBT [10]. Research on this possible association is required. 
 There are some limitations to this study. First, we do not have a control group; it is 
therefore unclear whether changes experienced by patients resulted from the CBT treatment, 
natural evolution, or other variables. A control group could have given the study more 
strength. However, a control group with an indication for the group therapy which did not 
receive the therapy, was not possible in our service. Second, we couldn’t not perform analyses 
to compare the patients who dropped out before ending the group therapy and those who 
completed the programme. These analyses would have been interesting with regard to the 
impact of personality characteristics on drop out and to generalize our findings. Third, more 
adequate data in the literature for calculating clinical significant cut-off points should be 
encouraged. It might also be that the clinically change results are underestimated because of 
the stringent cut-off points. This is especially true for patients with chronic illnesses such as 
CFS, in which a full ‘recovery’ based on crossing the cut-off is often difficult to achieve [8]. 
Fourth, the size of our sample is appropriate and comparable with other studies, but still not 
large (n=80). Fifth, studies on the mediating effect of acceptance change and long-term 
follow-up are recommended to provide more insight on the impact of change in acceptance on 
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*= p<0.001; **=p<0.0001**          
                 
Norm Independent Cohen's d: > 0.15 en <0.40 = small effect      
    > 0.40 en <0.75 = moderate effect     
    > 0.75 en <1.10 = large effect      















Recovered = fulfilled both conditions : RCI >1.96 (p<.05) and crossed over the cut-off point  
Improved  = fulfilled RCI >1.96 (p<.05)  
Detoriated = fulfilled RCI >1.96 (p<.05) in negative direction  






Table 3. Linear regression analyses with acceptance and neuroticism pre-treatment as 
independent variables. 
 
Outcome Predictors Step Adj R2 R2 Change B Beta P 
MQoLchange Neuroticism 1 .06 .07* .28 .15 .21 
 Acceptance 2 .10 .05* -1.22 -.26 .04* 
        








Treatment effect  
[95% CI] 
 
Effect size (Cohen’s d) 
[95% CI] 
MQoL 50.98 (18.27) 57.20 (14.85) 6.22 [2.65 to  9.79]*  .37 [.15 to .58] 
PQoL 30.03 (11.40) 34.23 (12.97)    4.19 [1.75 to 6.63]*  .34 [.14 to .54] 
Acceptance  11.73 (3.35) 13.91 (3.71) 2.19 [1.43 to 2.95]** .61 [.38 to .85] 
Fatigue severity 6.43 (.55) 6 (.89) -.42 [-.61 to -.24]**  -.56 [-.82 to -.31] 
Measure n  Recovered (%)  Improved (%) Detoriated (%) 
MQoL 
 
80 0 16 (20) 4 (5) 
PQoL 
 
80 6 (7.5) 21 (26.25) 7 (8.75) 
Acceptance 
 
80 4 (5) 19 (23.75) 2 (2.5) 
Fatigue 
 
80 13 (16,25) 32 (40) 8 (10) 
